- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT06614543
Feasibility Testing of Plant-Based Supplemented Food Products Made With Manitoba Crop Ingredients for Weight Loss
The purpose of this study is to advance the development of the WI/CDIC supplemented foods by evaluating the acceptance and feasibility of the supplemented food bars within the Wellness Institute's Weight Loss Clinic program (WLC) or an equivalent weight loss program in Winnipeg or the surrounding area. The main questions it aims to answer are:
- To determine whether the incorporation of WI/CDIC supplemented foods into the WI weight loss clinic design is feasible.
- To determine whether weight loss is supported by a plant-based supplemented food.
- To assess efficacy of the supplemented food by measuring changes in lifestyle behaviours and risk factors for chronic disease compared to non-supplemented food weight loss program members.
Researchers will compare the WLC program plus supplemented food to the WLC program without the supplemented food to evaluate the implementation of the supplemented foods into the WLC.
Participants will follow their WLC program for the initial 16 weeks, and those in the intervention group will begin their supplemented food. Participants will consume one supplemented food bar each day and will record this in the product consumption log.
Tutkimuksen yleiskatsaus
Yksityiskohtainen kuvaus
This is a pilot evaluation of the feasibility of incorporating the WI/CDIC supplemented food into the WI's newly designed WLC. This study will employ a mixed methods quasi-experimental approach using questionnaires and data collected over the evaluation period. Following consent, participants will be asked to fill out a set of questionnaires, to capture dietary intake, and to wear an activity monitor; to measure diet, physical activity, QOL and sleep before each study meeting. Eligible participants (n=40) will be randomized to intervention (supplemented food) or no intervention. Participants will attend two in-person study visits - one at the initiation and one at the completion of the 16-week weight loss program. Body weight, height, waist circumference, blood pressure and heart rate will be recorded at these two time points as well, as collected through the weight loss clinic program. Participants will also complete an exit questionnaire at the second visit that will include a 9-point hedonic scale to evaluate product acceptability.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Kathy Cherepak, BSc
- Puhelinnumero: 204-631-3834
- Sähköposti: kcherepak@sogh.mb.ca
Tutki yhteystietojen varmuuskopiointi
- Nimi: Dr Dylan MacKay, PhD
- Puhelinnumero: 204-272-3119
- Sähköposti: Dylan.Mackay@umanitoba.ca
Opiskelupaikat
-
-
Manitoba
-
Winnipeg, Manitoba, Kanada, R2V 3M3
- Seven Oaks Hospital Chronic Disease Innovation Centre
-
Ottaa yhteyttä:
- Kathy Cherepak, BSc
- Puhelinnumero: 204-631-3834
- Sähköposti: kcherepak@sogh.mb.ca
-
Alatutkija:
- Dr Rebecca Mollard, PhD
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Male or female, aged 18 years or above
- Live within the province of MB
- Ability to give written informed consent in English.
- Enrolled in the Wellness Institute Weight Loss Clinic or an equivalent, approved weight loss program in Winnipeg or the surrounding area.
Exclusion Criteria:
- Female participant who is pregnant, lactating or planning pregnancy during the course of the program.
- Participants with known allergies to the supplemented food ingredients
- Has an active eating disorder
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Active Comparator: The WLC program plus supplemented food
Participants in weight loss clinic program will consume one supplemented food bar each day and will record this in the product consumption log. |
These supplemented foods provide plant-based protein, fibre and fatty acids that have been shown to have health benefits related to chronic disease. |
|
Ei väliintuloa: The WLC program only
Participants in the weight loss clinic only. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Feasibility of incorporating the WI/CDIC supplemented foods into the WI weight loss clinic.
Aikaikkuna: End of Study (Week 16)
|
Feasibility will be demonstrated if the following five criteria are met:
|
End of Study (Week 16)
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Changes in Body Weight
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Body weight will be measured in kg to the nearest 0.1 kg by an exercise professional. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Waist Circumference
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Waist circumference in cm will be measured to the nearest 0.1 cm at the umbilicus, between the last rib and iliac crest using a fibreglass tape measured by an exercise professional. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in BMI
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Body Mass Index will be calculated using the formula BMI = kg/m2; where kg is the weight in kilograms and m2 is height in metres squared. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Cardiovascular Assessment
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Using the Framingham Risk Score, cardiovascular risk will be calculated based on age, HDL-C, total cholesterol, systolic blood pressure, smoking status, and diabetes status to determine the participant's 10-year risk of cardiovascular disease and identification of metabolic syndrome. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes is Quality of Life
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Quality of life will be measured through the SF-36 quality of life questionnaire. The SF-36 measures nine areas: physical functioning, role functioning (emotional), role functioning (physical), energy/fatigue, emotional well-being, social functioning, pain, general health, and health change. A higher score indicates greater levels of quality of life. |
At Enrollment (Week 0) and End of Study (Week 16)
|
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Changes in Systolic Blood Pressure
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Systolic blood pressure in mmHg is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Diastolic Blood Pressure
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Diastolic blood pressure in mmHg is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Heart Rate
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Heart rate in beats per minute is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Physical Activity
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Measured using the International Physical Activity Questionnaire - Short Form - (IPAQ-S) |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Change in Physical Activity Behaviour Patterns
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Assessed using total active minutes per day as measured by multi-directional accelerometry for 7 days. Participants will be asked to wear the accelerometer at all times. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake Behaviours
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Dietary intake behaviours will be measured through The Mindful Eating Questionnaire. The Mindful Eating Questionnaire recognizing patterns of overeating or eating in response to stress, boredom, or other emotions. Scoring is based on five categories, which include Awareness (being aware of how food looks, tastes and smells); Distraction (focusing on other things while eating); Disinhibition (eating even when full); Emotional Response (eating in response to sadness or stress); and External Cues (eating in response to environmental cues, such as advertising) |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake Behaviours
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Changes in dietary intake behaviours will be measured through the Three Factor Eating Questionnaire which is comprised of 18 items, measuring uncontrolled eating, restrained eating and emotional eating. The higher the score represents more dependency to cognition, stress or emotion the eating patterns. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Number of Meals
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Number of meals will be captured with a meal being defined as food intake greater than 500 kcal. Dietary intake will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Number of Snacks
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Number of snacks will be captured with a meal being defined as food intake less than 500 kcal. Dietary intake will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Energy
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Energy will be measured in kCals and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Protein
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Protein will be measured in grams and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Fat
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Fat will be measured in grams and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Available Carbohydrates
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Available carbohydrates will be measured in grams and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Dietary Intake - Fibre
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Fibre will be measured in grams and will be captured using the RxFood app. RxFood is a type of AI-driven, image based dietary assessment tool that has already demonstrated clinical benefits in various adult and pediatric clinical settings and in research as a data collection tool. Strong correlation and strength of agreement have been illustrated between RxFood and nutrient estimates from Esha's Research Nutrition analysis software, which is an industry choice for nutritional analysis and regulatory compliance (Jefferson et al, 2020). |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Sleep Patterns
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
An ActiGraph activity monitor will be used to measure sleep quality patterns for 7 days, with participants asked to wear the monitor at all times, including when they sleep. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Total Cholesterol
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in High density lipoprotein cholesterol
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Low density lipoprotein cholesterol
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Triglycerides
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Total Cholesterol and High-Density Lipoprotein Cholesterol Ratio
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
|
Changes in Hemoglobin A1C
Aikaikkuna: At Enrollment (Week 0) and End of Study (Week 16)
|
Diagnostic Services of Manitoba will collect and process the participants blood samples and measure the total cholesterol concentration in mmol/L according to their established protocols. |
At Enrollment (Week 0) and End of Study (Week 16)
|
Yhteistyökumppanit ja tutkijat
Sponsori
Yhteistyökumppanit
Tutkijat
- Päätutkija: Dr Dylan MacKay, PhD, University of Manitoba
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- HS26095 (B2023:073)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
De-identified individual participant data (IPD) may be placed in a repository if required by a journal for publication purposes. De-identified IPD may also be requested from the principle investigator.
IPD-jaon aikakehys
Data will become available following the publication of the primary results manuscript.
IPD-jaon käyttöoikeuskriteerit
Researchers who provide a methodologically sound proposal and whose proposed use of the data has been approved by the trial PI.
IPD-jakamista tukeva tietotyyppi
- STUDY_PROTOCOL
- MAHLA
- ICF
- ANALYTIC_CODE
- CSR
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .